Inari Medical said it has enrolled the first patient in the ClotTriever Outcomes Registry (“CLOUT”) using its ClotTriever thrombectomy system.
The ClotTriever device is designed to remove blood clots from large vessels in the peripheral vasculature via access sites as small as 6 mm.
CLOUT is a 500-patient prospective, multicenter, single-arm registry to evaluate real-world outcomes after treatment of patients with thrombosis in the deep veins of the lower extremity with ClotTriever. Dr. William Marston, chief of vascular surgery at the University of North Carolina, and Dr. Robert Beasley, section chief of vascular and interventional radiology at Mount Sinai Medical Center, are co-principal investigators.
Get the full story on our sister site, Medical Design & Outsourcing.
The post Inari begins ClotTriever outcome study appeared first on MassDevice.
from MassDevice https://ift.tt/2R1UbSl
Cap comentari:
Publica un comentari a l'entrada